DK0858337T3 - Farmaceutisk præparat til behandling af autoimmune sygdomme - Google Patents

Farmaceutisk præparat til behandling af autoimmune sygdomme

Info

Publication number: DK0858337T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; pct; treatment; autoimmune diseases; date
Prior art date: 1995-10-31

Application number

DK96937258T

Other languages

Danish (da)

English (en)

Inventor

Angelo Guglielmotti

Paolo Dionisio

Original Assignee

Acraf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-31

Filing date

1996-10-26

Publication date

2006-09-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11372453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0858337(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-10-26 Application filed by Acraf filed Critical Acraf

2006-09-18 Application granted granted Critical

2006-09-18 Publication of DK0858337T3 publication Critical patent/DK0858337T3/da

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
208000023275 Autoimmune disease Diseases 0.000 title 1
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
229960003444 immunosuppressant agent Drugs 0.000 abstract 1
230000001861 immunosuppressant effect Effects 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Neurology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)

DK96937258T 1995-10-31 1996-10-26 Farmaceutisk præparat til behandling af autoimmune sygdomme DK0858337T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT95MI002242A IT1276031B1 (it)	1995-10-31	1995-10-31	Composizione farmaceutica per il trattamento delle malattie autoimmuni

Publications (1)

Publication Number	Publication Date
DK0858337T3 true DK0858337T3 (da)	2006-09-18

Family

ID=11372453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96937258T DK0858337T3 (da)	1995-10-31	1996-10-26	Farmaceutisk præparat til behandling af autoimmune sygdomme

Country Status (26)

Country	Link
US (1)	US6020356A (fr)
EP (1)	EP0858337B1 (fr)
JP (1)	JP4007615B2 (fr)
KR (1)	KR19990067237A (fr)
CN (1)	CN1229113C (fr)
AT (1)	ATE326965T1 (fr)
AU (1)	AU721841B2 (fr)
BR (1)	BR9611320B1 (fr)
CA (1)	CA2236256C (fr)
CZ (1)	CZ292258B6 (fr)
DE (1)	DE69636167T2 (fr)
DK (1)	DK0858337T3 (fr)
EA (1)	EA000826B1 (fr)
ES (1)	ES2264144T3 (fr)
HU (1)	HU228051B1 (fr)
IL (1)	IL124291A (fr)
IT (1)	IT1276031B1 (fr)
MX (1)	MX9803478A (fr)
NO (1)	NO324130B1 (fr)
NZ (1)	NZ321580A (fr)
PL (1)	PL186377B1 (fr)
PT (1)	PT858337E (fr)
SK (1)	SK284069B6 (fr)
TR (1)	TR199800765T2 (fr)
WO (1)	WO1997016185A2 (fr)
ZA (1)	ZA969060B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6323201B1 (en)	1994-12-29	2001-11-27	The Regents Of The University Of California	Compounds for inhibition of ceramide-mediated signal transduction
IT1293795B1 (it)	1997-07-28	1999-03-10	Angelini Ricerche Spa	Farmaco attivo nel ridurre la produzione di proteina mcp-1
ATE445393T1 (de) *	2003-04-24	2009-10-15	Jagotec Ag	Tablette mit gefärbtem kern
SG174026A1 (en)	2006-08-03	2011-09-29	Nitec Pharma Ag	Delayed-release glucocorticoid treatment of rheumatoid disease
ITMI20062254A1 (it) *	2006-11-24	2008-05-25	Acraf	Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AU2010207740B2 (en) *	2009-01-26	2016-06-16	Nitec Pharma Ag	Delayed-release glucocorticoid treatment of asthma
SG176885A1 (en)	2009-08-03	2012-01-30	Acraf	Process for the preparation of 1-benzyl-3-hydr0xymethyl-1h-indaz0le and its derivatives and required magnesium intermediates
UA108742C2 (uk) *	2009-09-23	2015-06-10		Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
EP3338776A1 (fr) *	2012-05-01	2018-06-27	Translatum Medicus Inc.	Procédé de traitement et de diagnostic de maladies menant à la cécité
US8999292B2 (en)	2012-05-01	2015-04-07	Translatum Medicus Inc.	Methods for treating and diagnosing blinding eye diseases
EP3990433B1 (fr)	2019-06-25	2026-05-20	Translatum Medicus Inc	Procédés de fabrication d'acide 2-((1-benzyl-1h-indazol-3-yl)méthoxy)-2-méthylpropanoïque et de ses dérivés

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990015816A1 (fr) *	1989-06-16	1990-12-27	The Upjohn Company	Composes du type suramine et steroides angiostatiques inhibiteurs de l'angiogenese
IT1253703B (it) *	1991-04-22	1995-08-23	Angelini Francesco Ist Ricerca	Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
US5770589A (en) *	1993-07-27	1998-06-23	The University Of Sydney	Treatment of macular degeneration
AU7376494A (en) *	1993-08-04	1995-02-28	Andrulis Pharmaceuticals Corporation	Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
US5434170A (en) *	1993-12-23	1995-07-18	Andrulis Pharmaceuticals Corp.	Method for treating neurocognitive disorders
JPH10506632A (ja) *	1995-05-10	1998-06-30	ファイザー・インコーポレーテッド	慢性関節リウマチを治療するためのメトトレキセートとテニダップとの組合せ物

1995
- 1995-10-31 IT IT95MI002242A patent/IT1276031B1/it active IP Right Grant
1996
- 1996-10-26 CZ CZ19981326A patent/CZ292258B6/cs unknown
- 1996-10-26 JP JP51705397A patent/JP4007615B2/ja not_active Expired - Fee Related
- 1996-10-26 BR BRPI9611320-0A patent/BR9611320B1/pt active IP Right Grant
- 1996-10-26 ES ES96937258T patent/ES2264144T3/es not_active Expired - Lifetime
- 1996-10-26 TR TR1998/00765T patent/TR199800765T2/xx unknown
- 1996-10-26 DK DK96937258T patent/DK0858337T3/da active
- 1996-10-26 IL IL12429196A patent/IL124291A/en not_active IP Right Cessation
- 1996-10-26 EA EA199800417A patent/EA000826B1/ru not_active IP Right Cessation
- 1996-10-26 NZ NZ321580A patent/NZ321580A/en not_active IP Right Cessation
- 1996-10-26 EP EP96937258A patent/EP0858337B1/fr not_active Expired - Lifetime
- 1996-10-26 SK SK579-98A patent/SK284069B6/sk not_active IP Right Cessation
- 1996-10-26 KR KR1019980703195A patent/KR19990067237A/ko not_active Ceased
- 1996-10-26 DE DE69636167T patent/DE69636167T2/de not_active Expired - Lifetime
- 1996-10-26 CA CA002236256A patent/CA2236256C/fr not_active Expired - Lifetime
- 1996-10-26 WO PCT/EP1996/004672 patent/WO1997016185A2/fr not_active Ceased
- 1996-10-26 CN CNB96199472XA patent/CN1229113C/zh not_active Expired - Lifetime
- 1996-10-26 PT PT96937258T patent/PT858337E/pt unknown
- 1996-10-26 PL PL96326371A patent/PL186377B1/pl unknown
- 1996-10-26 HU HU9901303A patent/HU228051B1/hu unknown
- 1996-10-26 US US09/068,011 patent/US6020356A/en not_active Expired - Lifetime
- 1996-10-26 AU AU74938/96A patent/AU721841B2/en not_active Expired
- 1996-10-26 AT AT96937258T patent/ATE326965T1/de active
- 1996-10-28 ZA ZA969060A patent/ZA969060B/xx unknown
1998
- 1998-04-29 NO NO19981951A patent/NO324130B1/no not_active IP Right Cessation
- 1998-04-30 MX MX9803478A patent/MX9803478A/es unknown

Also Published As

Publication number	Publication date
CZ292258B6 (cs)	2003-08-13
CA2236256A1 (fr)	1997-05-09
JP4007615B2 (ja)	2007-11-14
WO1997016185A3 (fr)	1997-07-03
MX9803478A (es)	1998-11-30
DE69636167D1 (de)	2006-06-29
SK57998A3 (en)	1998-12-02
PL186377B1 (pl)	2003-12-31
TR199800765T2 (xx)	1998-08-21
IT1276031B1 (it)	1997-10-24
NZ321580A (en)	2000-02-28
ITMI952242A1 (it)	1997-05-01
EA199800417A1 (ru)	1998-10-29
KR19990067237A (ko)	1999-08-16
ATE326965T1 (de)	2006-06-15
ES2264144T3 (es)	2006-12-16
HUP9901303A2 (hu)	1999-09-28
IL124291A (en)	2001-06-14
EP0858337A2 (fr)	1998-08-19
AU7493896A (en)	1997-05-22
DE69636167T2 (de)	2007-03-29
NO981951L (no)	1998-06-29
CN1229113C (zh)	2005-11-30
ZA969060B (en)	1997-05-29
BR9611320A (pt)	1999-03-02
NO981951D0 (no)	1998-04-29
ITMI952242A0 (fr)	1995-10-31
HU228051B1 (en)	2012-09-28
AU721841B2 (en)	2000-07-13
JPH11515020A (ja)	1999-12-21
EA000826B1 (ru)	2000-04-24
BR9611320B1 (pt)	2010-08-10
NO324130B1 (no)	2007-09-03
CA2236256C (fr)	2005-02-22
US6020356A (en)	2000-02-01
SK284069B6 (sk)	2004-09-08
WO1997016185A2 (fr)	1997-05-09
HUP9901303A3 (en)	2001-04-28
CN1207042A (zh)	1999-02-03
CZ132698A3 (cs)	1998-10-14
EP0858337B1 (fr)	2006-05-24
HK1018219A1 (en)	1999-12-17
PT858337E (pt)	2006-09-29
PL326371A1 (en)	1998-09-14

Publication	Publication Date	Title
BG104620A (en)	2001-04-30	Oral pharmaceutical extended release dosage form
ES2128761T3 (es)	1999-05-16	Formulacion de tirilazad con cosolvente para administracion parenteral.
DK0713490T3 (da)	1998-05-11	Ringstabiliserede rapamycinderivater
DK0703786T3 (da)	2002-05-27	Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
NO995006D0 (no)	1999-10-14	Nye forbindelser
ES2179040T3 (es)	2003-01-16	Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
DK1293207T3 (da)	2009-10-05	Anvendelse af ritonavir (ABT-538) til forbedring af farmokokinetikken af lægemidler, som metaboliseres af cytochrome P450 i en fremgangsmåde til at behandle AIDS
DK1014966T3 (da)	2006-12-04	Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
IT1276031B1 (it)	1997-10-24	Composizione farmaceutica per il trattamento delle malattie autoimmuni
PT921787E (pt)	2004-03-31	Regime de administracao de inibidores de atpase de h',k'
DE60102590T2 (de)	2005-04-21	Darreichungsformen zur behandlung von oralen mykosen
ATE319715T1 (de)	2006-03-15	Antikonvulsive pseudofructopyranose sulfamate
ATE235901T1 (de)	2003-04-15	Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
DK1150704T3 (da)	2006-06-12	Melagatran til behandling af betændelse
GEP20063719B (en)	2006-01-10	Prevention of Migraine Recurrence
ES2172182T3 (es)	2002-09-16	Composiciones farmaceuticas que comprenden cefuroxima axetil.
NO984651L (no)	1998-12-03	Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
ATE293445T1 (de)	2005-05-15	Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
WO1998038986A3 (fr)	1999-01-14	Medicament pour la prevention et la therapie d'infections virales
WO1998038985A3 (fr)	1998-12-23	Medicament pour la prophylaxie et le traitement des maladies inflammatoires
MX9706825A (es)	1997-11-29	El uso farmacologico de ciertos derivados de cistina.